We are investigating the safety and effectiveness of DFV890 in adults with myeloid diseases. This study aims to understand how well this treatment works and how it is tolerated.
Health conditions and diseases that the clinical trial is designed to study and treat.
Myeloid dysplasia, also known as myelodysplastic syndrome (MDS), is a group of disorders caused by poorly formed or dysfunctional blood cells in the bone marrow, leading to symptoms like fatigue, frequent infections, and easy bruising or bleeding.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
